By comparing the prognosis of HCC patients with high expression and low expression of ZNF529-AS1, we found a significant difference between the two groups (the higher the expression level was, the shorter the survival time), and ZNF529-AS1 was an independent factor affecting the prognosis of HCC patients. Here, ZNF529 is linked to hepatocellular carcinoma.